RESPECT

Falcon Oil & Gas Ltd - Results of Fundraising

Retrieved on: 
Monday, April 22, 2024
ACT, RESPECT, THIS, FOG, Daly Waters, Fundraising, AIM, FCA, ANY, WERE, Beetaloo, Book building, TSX Venture Exchange, WITH, AS, EUROPEAN UNION, Indian stock exchange, VIA, Subscription business model, Cryptocurrency

Falcon Oil & Gas Ltd (AIM: FOG, TSXV: FO.V), the international oil and gas company engaged in the exploration and development of unconventional oil and gas assets, is pleased to confirm the results of the proposed Fundraising announced by the Company on 18 April 2024.

Key Points: 
  • Falcon Oil & Gas Ltd (AIM: FOG, TSXV: FO.V), the international oil and gas company engaged in the exploration and development of unconventional oil and gas assets, is pleased to confirm the results of the proposed Fundraising announced by the Company on 18 April 2024.
  • As previously announced, alongside the Fundraising, Falcon Oil & Gas Australia Limited (“Falcon Australia”) has agreed to grant Daly Waters Energy, LP (“Daly Waters”) and a major US-based energy industry service provider overriding royalty interests (“ORRIs”) over Falcon Australia’s working interests in the Beetaloo Sub-Basin exploration permits in return for cash payments of US$3 million and US$1 million, respectively.
  • Thomas Layman, a Director of the Company, participated in the Fundraising.
  • The number of New Common Shares conditionally subscribed for by him pursuant to the Subscription, and his resulting shareholding on First Admission, is set out below:

Falcon Oil & Gas Ltd - Proposed Fundraising and grant of ORRIs to raise gross proceeds of approximately $8.5 million (£6.8 million)

Retrieved on: 
Thursday, April 18, 2024
ACT, Permian, Sasol, RESPECT, Tanumbirini, IP30, JV, THIS, FOG, Person, Fundraising, Bookrunner, AIM, FCA, Attention, ANY, WERE, Admission, Book building, Origin Energy, Issue, WITH, AS, Porosity, Place, Sale, EUROPEAN UNION, Pioneer Natural Resources, Announcement, Indian stock exchange, VIA, Holding company

Completion of the grant of the ORRIs is subject to agreement of final legal documentation and to submission to the Northern Territory Government, Australia for registration.

Key Points: 
  • Completion of the grant of the ORRIs is subject to agreement of final legal documentation and to submission to the Northern Territory Government, Australia for registration.
  • Falcon is an international oil and gas company focused on the exploration and appraisal of unconventional oil and gas assets, with the current portfolio focused in Australia, South Africa and Hungary.
  • In 2020, Falcon Australia farmed down a further 7.5% and Origin agreed to increase the gross cost cap of the work program by A$150.5 million (c.US$97 million) to A$263.8 million (c.US$170 million).
  • PE was acquired for over US$7 billion by Pioneer Natural Resources Company (“Pioneer”), itself a leading independent oil and gas company.

BIONDI-SANTI LAUNCHES BRUNELLO DI MONTALCINO 2018

Retrieved on: 
Friday, March 1, 2024
Estate, Wine, Human voice, Ageing, Reserve wine, RESPECT, Season, History, La Voce, Brunello di Montalcino, QR, HERE, Wind, Viticulture

NEW YORK, March 1, 2024 /PRNewswire/ -- Biondi-Santi, the legendary Brunello di Montalcino producer, is pleased to announce the release of the 2018 vintage of Brunello di Montalcino.

Key Points: 
  • NEW YORK, March 1, 2024 /PRNewswire/ -- Biondi-Santi, the legendary Brunello di Montalcino producer, is pleased to announce the release of the 2018 vintage of Brunello di Montalcino.
  • The La Voce di Biondi-Santi audio experience will accompany each bottle of Brunello di Montalcino 2018, and wine lovers can access the listening experience by scanning the QR code on the proof tag on the capsule of the bottles.
  • 'La Voce di Biondi-Santi' is something we very much enjoy sharing with our customers and collectors, and we're excited to include it as part of our formal presentation of the 2018 Brunello this spring."
  • Commenting on the growing seasons for the 2018 Brunello di Montalcino, Federico Radi, Director of Viticulture and Winemaking, shares:
    "2018 was quite a cool year, characterized by abundant rainfalls which accompanied the entire growth cycle of the vine.

GordonMD® Announces Second Investment in Radiopharmaceutical Biotech Radionetics Oncology

Retrieved on: 
Friday, January 5, 2024
Radiology, Biotechnology, Pharmaceutical, Finance, Oncology, Health, Professional Services, Clinical Trials, NOT, ANY, MD, Investment, Growth, RESPECT

GordonMD® Global Investments LP, a key investor in groundbreaking healthcare solutions, announced another strategic investment in Radionetics Oncology.

Key Points: 
  • GordonMD® Global Investments LP, a key investor in groundbreaking healthcare solutions, announced another strategic investment in Radionetics Oncology.
  • Radionetics Oncology , a clinical stage radiopharmaceutical company, successfully secured a $52.5 million Series A financing round, led by Frazier Life Sciences, 5AM Ventures, and DCVC Bio, along with participation from GordonMD® and Crinetics Pharmaceuticals, bringing its total raised capital to $82.5 million.
  • “I believe Radionetics Oncology is poised to revolutionize cancer treatment with its pioneering radiopharmaceutical pipeline.
  • The firm focuses on identifying differentiated investment opportunities in biopharmaceutical companies primarily located in the U.S., Europe and Japan.

GordonMD® Announces Investment in Radiopharmaceutical Biotech Radionetics Oncology

Retrieved on: 
Tuesday, October 17, 2023
Research, Finance, Clinical Trials, Professional Services, Biotechnology, Radiology, Pharmaceutical, Health, Science, Oncology, Cancer, Lung cancer, Investment, Breast cancer, MD, Radionuclide, Therapy, Radiopharmaceutical, NOT, RESPECT, ANY, Neoplasm, Adrenocortical carcinoma, Venture, Pharmaceutical industry

Craig Gordon, MD, Chief Executive Officer of GordonMD® Global Investments LP, announced today that his firm has jointly invested in a private placement financing for Radionetics Oncology.

Key Points: 
  • Craig Gordon, MD, Chief Executive Officer of GordonMD® Global Investments LP, announced today that his firm has jointly invested in a private placement financing for Radionetics Oncology.
  • Radionetics Oncology, a clinical stage pharmaceutical company spun out of Crinetics (Nasdaq: CRNX) in 2021, focuses on the discovery and development of novel radiotherapeutics for the treatment of a wide range of oncology indications.
  • GordonMD® joins Frazier Healthcare, 5AM Ventures, and Crinetics Pharmaceuticals as investors in Radionetics.
  • “I believe Radionetics Oncology presents a unique investment opportunity.

Scilex Holding Company Provides Notice to All Record Holders and Beneficial Owners of Restricted Shares of Scilex Holding Company

Retrieved on: 
Tuesday, October 3, 2023
Transfer, ACT, ENTRY, Proposal, AS, Chapter 11, Title 11, United States Code, Official Committee of Equity Security Holders, CASH, Equity, Continental, CALL, United States bankruptcy court, OF, WITH, PUT, Bankruptcy, PALO, RESPECT, OR, NET, SMA, SELL, SALE, BY, DEADLINE, Documentation, ANY, OTC, COMMON, Chronic pain, Security (finance), Real estate, Debtor, Short, Lock up

The Scilex Dividend Stock was primarily received by “record holders,” or brokers, dealers, banks and other nominees acting as agents for shareholders who are the true “beneficial owners” of the Scilex Dividend Stock.

Key Points: 
  • The Scilex Dividend Stock was primarily received by “record holders,” or brokers, dealers, banks and other nominees acting as agents for shareholders who are the true “beneficial owners” of the Scilex Dividend Stock.
  • “Naked short” sales or “naked short” positions in any Scilex common stock may constitute a violation of SEC Regulation SHO.
  • If a holder of a short-position already holds unrestricted shares of Scilex common stock, such holder may convert such shares into restricted shares subject to the Lockup via the same process outlined herein.
  • b. Scilex and the buyer will jointly instruct Continental Stock Transfer & Trust Company, Scilex’s transfer agent (“Continental”), to impose the Lockup on the shares.

How long will a loved one live? It’s difficult to hear, but harder not to know

Retrieved on: 
Monday, September 25, 2023
Life, RESPECT, Survival, Quality of life, Terminal, Statistics, Dignity, Research, Goal, Life expectancy, Translation, Nursing, Intention, Retirement, Patient, Cooking, Frailty, Learning, Algorithm, Community Tool Box, Palliative care, Project, Risk, Mathematics, Health, Death, Residential care, Pharmaceutical industry, Medical device, Transport

Clinicians, based on their experience, can offer broad estimates of survival — in days to weeks, weeks to months, or months to years.

Key Points: 
  • Clinicians, based on their experience, can offer broad estimates of survival — in days to weeks, weeks to months, or months to years.
  • However, patients and their care partners often want greater precision when arranging or making decisions about their care.
  • However, even for an experienced clinician, estimating the life expectancy of a patient with a serious illness is challenging.

A tool for timely conversations and planning

    • RESPECT (Risk Evaluation for Support: Predictions for Elder life in their Communities Tool) is a risk communication tool powered by prediction algorithms that estimate individuals’ survival — that is, how long someone will live.
    • RESPECT was designed with patients’ information needs in mind, and with the intention of empowering patients and their care partners.

A tool for patients, care partners and clinicians

    • Older adults, their care partners and health care professionals who are uncertain about the life expectancy of someone living with a critical illness can use the calculator to gain a better understanding of their decline.
    • A patient can use this information to discuss their care needs with their care partners and health-care providers.
    • Earlier conversations about the older person’s goals and wishes for their remaining life can enable the care team to provide the best quality of life and care for the individuals under their care.

Sustainable infrastructure

    • One of the goals of RESPECT is to provide sustainable infrastructure to study, learn and improve how we use predictive algorithms for end-of-life care.
    • Despite the benefits that are emerging from the early uses of RESPECT, many questions remain about when and how it can be most appropriately used.

Identification is just the first step

    • Lysanne Lessard receives funding from Canadian Institutes of Health Research for research related to the RESPECT Learning Health System.
    • Amy T. Hsu receives funding from the Canadian Institutes of Health Research for research related to the RESPECT Calculator.
    • Peter Tanuseputro receives funding from the Canadian Institutes of Health Research for research related to the RESPECT calculator.

AI is quietly building financial intelligence for younger Canadians, yet skepticism remains, reveals new RBC Survey

Retrieved on: 
Monday, August 28, 2023
Tilton, RBC, GPS, Ipsos, Personal, RESPECT, Perception, Save, Customer experience, Commercial bank, Machine learning, Artificial intelligence, Ageing, AI, Digital, Sales, Dairy, Medical device, Customer service

From automated savings and budgeting to quick insights and cash flow forecasting, AI quietly yet significantly changes how Canadians can handle their finances.

Key Points: 
  • From automated savings and budgeting to quick insights and cash flow forecasting, AI quietly yet significantly changes how Canadians can handle their finances.
  • "We believe AI is revolutionizing personal finance management," says Peter Tilton, chief digital officer, Personal & Commercial Banking at RBC.
  • "The ability to harness the power of AI can help level the playing field in terms of financial literacy for Canadians.
  • With RBC's renowned digital team and Borealis AI, an RBC-backed AI research center, RBC continues to innovate and explore the development of responsible AI.

GordonMD® Invests in Private Placement for Taysha Gene Therapies

Retrieved on: 
Monday, August 21, 2023
Biotechnology, Health, Genetics, Pharmaceutical, Clinical Trials, NOT, Central nervous system, Civil service commission, Investment, RESPECT, Rett syndrome, MECP2, AAV, CNS, Giant axonal neuropathy, Orphan drug, GAN, MD, Risk, ANY, Rare, FDA, Notre Dame Institute for Global Investing, European Commission, Pharmaceutical industry

GordonMD® Global Investments LP announced today it has participated in a $150 million private placement financing for Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system (CNS).

Key Points: 
  • GordonMD® Global Investments LP announced today it has participated in a $150 million private placement financing for Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system (CNS).
  • Rett syndrome is a rare genetic neurodevelopmental disorder caused by mutations in the X-linked MECP2 gene.
  • TSHA-102 utilizes a novel miRARE platform designed to mediate levels of MECP2 in the CNS on a cell-by-cell basis without risk of overexpression.
  • The firm manages a private fund and a public fund, each focused on differentiated investment opportunities in biopharmaceutical companies primarily located in the U.S., Europe and Japan.

THE BARBARA SINATRA CHILDREN'S CENTER TO DEBUT SHORT FILM "ARE YOU LISTENING?" TO RAISE AWARENESS FOR YOUTH-ON-YOUTH CONSENT

Retrieved on: 
Monday, August 21, 2023
Parent, RESPECT, Are You Listening, Army Heritage Center Foundation, Friends, Safety, Anybody's Nightmare, Toy

RANCHO MIRAGE, Calif., Aug. 21, 2023 /PRNewswire/ -- The Barbara Sinatra Children's Center Foundation released today a short film titled, Are You Listening? in collaboration with Wonder Media. This video was created as a part of The Barbara Sinatra Children's Center's FightChildAbuse.org Teen Series, focusing on the importance of youth-on-youth consent. According to the Center, youth who experience sexual assault are more likely to be victimized by a peer or a partner, and of the 1 in 4 girls who suffer some type of sexual assault by age 18, nearly 30% are victimized by a current partner.

Key Points: 
  • This short film was created with Wonder Media and will be a free, online resource available to teens, educators and parents
    RANCHO MIRAGE, Calif., Aug. 21, 2023 /PRNewswire/ -- The Barbara Sinatra Children's Center Foundation released today a short film titled, Are You Listening?
  • This video was created as a part of The Barbara Sinatra Children's Center's FightChildAbuse.org Teen Series, focusing on the importance of youth-on-youth consent.
  • This discovery helps Ivy, Taryn and Kai remember the importance of "ASK, LISTEN, RESPECT" in order to keep each other safe.
  • The film follows the Barbara Sinatra Children's Center Foundation's award-winning 2021 short film release, Are You Okay?